EPO Patents = 7

Forward Citations = 2

Loading Chart...

4 inventors (with patents filed for the assignee):

Angus Dalgleish (6 out of 18 patents)

Wai Lui (4 out of 4 patents)

Wai Liu (4 out of 9 patents)

4. Rachel Allen (1 patent)

5. Francis Hood (0 patent)

6. Ian Thompson (0 patent)

8 patents: Sort by Forward Citations

1. 12611405 - Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer (2026-04-28),

2. 12497663 - Method of monitoring treatment (2025-12-16),

3. 12324805 - Cancer treatment (2025-06-10),

4. 12144807 - Priming of cancer cells with low dose naltrexone (2024-11-19),

5. 12029737 - Autoimmune therapy (2024-07-09),

6. 11885796 - Assay to identify anti-cancer agents (2024-01-30),

7. 11351165 - Agent that increases the expression of the opioid kappa 1 for the treatment of cancer (2022-06-07),

8. 11304943 - Combination for use in the treatment of lung cancer (2022-04-19),

Ldn Pharma Limited is a leading pharmaceutical company specializing in the research, development, and production of innovative healthcare solutions. With a focus on improving patient outcomes and quality of life, Ldn Pharma is committed to providing high-quality medications and therapies to address a wide range of medical conditions. Our team of dedicated professionals is driven by a passion for excellence and a commitment to advancing the field of healthcare through innovation and collaboration.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

8 Patents

#380 in London

#2,094 in United Kingdom

London, United Kingdom

Ldn Pharma Limited